Halberd Corp (HALB)

[solidgold]

Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease

Press Release | 05/04/2021
JACKSON CENTER, PA / ACCESSWIRE / May 4, 2021 / Halberd Corporation (OTC PINK:HALB) announces the appointment of Dr. Mitchell S. Felder, previously a consultant to Halberd Corporation, to the position of Chief Technical Officer. Dr. Patricio Reyes, former Chief Technical Officer, has requested reduced duties due to pressing other outside commitments, but will continue to serve as a valuable contributor to the company moving forward, as a consultant.



Dr. Felder is a Board-Certified Neurologist and is the author of numerous patents, including critical patents on the development of radio frequency and laser emissive energy in the extracorporeal eradication of disease. Dr. Felder, in his new role, will oversee the coordination of testing in these fields at three university-affiliated organizations.

William A Hartman, President, CEO and Chairman stated, "This move will not only fill the spot vacated by Dr. Reyes, but is intended to maximize the benefits of our R&D tests at Youngstown State University, where we intend to conduct simultaneous experimentations on both radio frequency and laser methods to eradicate E. coli bacteria from water, as a prelude to eradicating disease from bodily fluids. Most of the required equipment and supplies have either been recently secured or are already on hand, and the start of testing is imminent. Tests on other pathogens, including Covid-19 will be conducted after demonstrating success in eliminating E. coli bacteria from distilled water, initially, and subsequently from human bodily fluids.

"Halberd's technology is protected via two existing patents on the requisite extra-corporeal (outside the body) process and eight related provisional patent applications filed in the last year.

"Our scientists believe that the advantage of radio frequency and lasers to eradicate disease antigens is that virtually no disease would be immune from these processes, and there would be virtually no known side effects from disease treatment. We are exploring both radio frequency and lasers to eradicate disease so that the most appropriate methodology can be applied to each specific disease. If successful, these processes could revolution the worldwide medical industry."

To get the latest news on Halberd's exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
https://www.otcmarkets.com/stock/HALB/news/Halberd-Corporation-Appoints-New-Chief-Technical-Officer-to-Optimize-Upcoming-Experiments-On-Radio-Frequency-and-Laser-E?id=301272